| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Health Catalyst, Inc. (HCAT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. HCAT is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.46M | $1.95M | - | |
| CEO | 1.39M | $1.87M | - | |
| CFO | 741.6K | $993.8K | - | |
| Other | 378.3K | $506.9K | - | |
| Other | 358.7K | $480.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Llewelyn Linda82 | Chief People Officer | Sell | 6,442 | $5.80 | $37,348.14 | -6.5% | -35.8% | -59.4% | |
| Jan 6, 2025 | Lesueur Daniel83 | Chief Operating Officer | Sell | 5,209 | $7.51 | $39,134.18 | -5.4% | -46.1% | -67.8% | |
| Jan 6, 2025 | Landry Benjamin84 | General Counsel | Sell | 2,500 | $7.52 | $18,795.50 | -3.3% | -46.1% | -67.8% | |
| Dec 30, 2024 | Gallagher Duncan63 | Director | Sell | 4,500 | $6.93 | $31,184.10 | -6.0% | -35.4% | -66.0% | |
| Dec 23, 2024 | Gallagher Duncan63 | Director | Sell | 4,500 | $6.98 | $31,415.40 | -5.7% | -35.7% | -66.1% | |
| Dec 16, 2024 | Llewelyn Linda82 | Chief People Officer | Sell | 6,442 | $7.88 | $50,793.88 | -6.1% | -43.3% | -68.9% | |
| Dec 6, 2024 | Alger Jason78 | Chief Financial Officer | Sell | 19,599 | $8.32 | $163,049.96 | -18.4% | -46.9% | -68.9% | |
| Dec 6, 2024 | Landry Benjamin84 | General Counsel | Sell | 19,268 | $8.32 | $160,294.35 | -21.1% | -46.9% | -68.9% | |
| Dec 4, 2024 | Lesueur Daniel83 | Chief Operating Officer | Sell | 22,773 | $7.70 | $175,242.79 | -19.1% | -43.0% | -66.1% | |
| Dec 2, 2024 | Freeman Kevin Lee64 | Chief Commercial Officer | Sell | 7,500 | $8.94 | $67,073.25 | -3.1% | -49.0% | -69.4% |